No Data
No Data
No Data
No Data
No Data
Saisheng Pharmaceutical (06600): 7,500 share options have been exercised
Saisheng Pharmaceutical (06600) issued an announcement. On April 23, 2024, the company's initial public offering of after-sales share purchase options...
Zhitong FinanceApr 23 10:25 ET
Saisheng Pharmaceutical (06600): 90,000 share options exercised
Saisheng Pharmaceutical (06600) announced that on April 22, 2024, the company will publicly launch an after-sales share purchase plan project for the first time...
Zhitong FinanceApr 22 09:59 ET
Saisheng Pharmaceutical (06600): 60,600 share options have been exercised
According to the Zhitong Finance App, Saisheng Pharmaceutical (06600) announced that on April 19, 2024, according to the rules of the initial public offering after-sales share option plan, the 86,400 share options granted under the initial public offering after-sales share option plan have expired; and the 60,600 share options granted under the initial public offering after-sales share option plan have been exercised.
Zhitong FinanceApr 19 10:52 ET
Saisheng Pharmaceutical announced that 180,000 share options have been granted and have been exercised
Saisheng Pharmaceutical (06600) announced that on April 18, 2024, according to the rules of the initial public offering after-sales share option plan: 7.167.36 million share options granted under the initial public offering after-sales share option plan have been vested; 706.84 million share options granted under the initial public offering after-sales share option plan have expired; and 180,000 share options granted under the initial public offering after-sales share option plan have been exercised.
新浪港股Apr 18 19:59 ET
Sciclone Pharmaceuticals to Dispatch Privatization Documents by May 31
Sciclone Pharmaceuticals (Holdings) (HKG:6600) sought an extension for the dispatch of the scheme document related to its privatization as it needs more time to finalize the document's content. The bi
MT NewswiresApr 18 09:21 ET
Saisheng Pharmaceutical announced the exercise of 10,000 share options
Saisheng Pharmaceutical (06600) announced that on April 15, 2024, 10,000 share options granted under the company's initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.
新浪港股Apr 15 20:25 ET
No Data
No Data